Mebeverine hydrochloride
Brand names: Colofac
Mebeverine hydrochloride is an antispasmodic used to relieve the abdominal pain and cramping of irritable bowel syndrome and related gastrointestinal spasm.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
It is a direct-acting smooth muscle relaxant that reduces intestinal spasm by acting locally on gut musculature, without the antimuscarinic effects typical of other antispasmodics.
Prescribing in practice
- It is contraindicated in paralytic ileus, where reducing gut motility could be harmful, and should not be relied upon if symptoms suggest a more serious bowel disorder.
- It is generally well tolerated; rare hypersensitivity reactions including rash and angioedema have been reported.
- Modified-release preparations should be swallowed whole and are typically taken before meals.
Monitoring
No specific laboratory monitoring is required; review symptom control and reconsider the diagnosis if there is no improvement or if alarm features develop.
Counselling the patient
- Take the dose shortly before meals as directed, swallowing modified-release capsules whole.
- Seek review if your pain changes, worsens, or you notice bleeding or unexplained weight loss.
Evidence & guidelines
Antispasmodics such as mebeverine are recommended by NICE as an option for managing abdominal pain and spasm in irritable bowel syndrome.
Reference: NICE CG61; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Lower Gastrointestinal Bleed · BSG 2019; NICE NG141
- Variceal Upper GI Bleed · BSG 2015; Baveno VII (2022)
- Spontaneous Bacterial Peritonitis (SBP) · BSG / EASL 2018
- Hepatorenal Syndrome · EASL 2018; ICA 2015
- Hepatic Encephalopathy · EASL 2014; West Haven criteria
- Clostridioides difficile Colitis · NICE NG199 (2021); IDSA/SHEA 2021